CUAMC
PRME icon

China Universal Asset Management Company’s Prime Medicine PRME Stock Holding History

China Universal Asset Management Company’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$106K Sell
28,745
-3,288
-10% -$10.9K 0.01% 411
2026
Q1 		$111K Buy
32,033
+2,619
+9% +$9.97K 0.01% 399
2025
Q4 		$102K Sell
29,414
-1,236
-4% -$5.5K 0.01% 409
2025
Q3 		$170K Buy
30,650
+4,280
+16% +$17.4K 0.01% 344
2025
Q2 		$65.1K Buy
26,370
+61
+0.2% +$94 0.01% 400
2025
Q1 		$52.4K Sell
26,309
-1,502
-5% -$3.83K ﹤0.01% 418
2024
Q4 		$81.2K Buy
27,811
+4,725
+20% +$16.6K 0.01% 415
2024
Q3 		$89.3K Buy
23,086
+8,985
+64% +$41.6K 0.01% 363
2024
Q2 		$72.5K Sell
14,101
-8,277
-37% -$50.2K 0.01% 322
2024
Q1 		$157K Buy
22,378
+11,120
+99% +$84.3K 0.02% 320
2023
Q4 		$99.7K Buy
+11,258
New +$86.7K 0.02% 279

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.74B AUM 36.19% 1-Year Est. Return
ACM
Alessandra Capital Management Torrance, California $141M AUM
CCC
Chelsea Counsel Company Los Angeles, California $236M AUM 51.76% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

China Universal Asset Management Company's PRME Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Prime Medicine (PRME) stake by 10% in Q2 2026, selling an estimated $10.9K and leaving 28,745 shares worth $106K. The position accounts for 0.01% of the portfolio, ranked #411.

China Universal Asset Management Company first reported a position in PRME in Q4 2023 and has held it in 11 quarters since. The position peaked at $170K in Q3 2025. 98 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • China Universal Asset Management Company held 28,745 shares of Prime Medicine worth $106K as of Q2 2026.
  • China Universal Asset Management Company sold 3,288 Prime Medicine shares in Q2 2026, an estimated $10.9K.
  • Prime Medicine made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #411 holding.
  • China Universal Asset Management Company first reported a position in Prime Medicine in Q4 2023 and has held it in 11 quarters since.
  • China Universal Asset Management Company's Prime Medicine position peaked at $170K in Q3 2025.
  • 98 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.